Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Recent Posts

2023-01-01 00:00:00

Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain-gut-microbiome interactions in irritable bowel syndrome: Preliminary findings

This study identifies disrupted brain-gut-microbiome interactions in BS patients, revealing altered brain network dynamics and microbial shifts linked to symptom severity and cognitive dysfunction. These findings highlight the potential for targeted therapies addressing both brain connectivity and gut microbiota to improve BS management.

2023-01-01 00:00:00

Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria

2023-01-01 00:00:00

Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor

2022-01-01 00:00:00

Study of gut microbiota alterations in Alzheimer’s dementia patients from Kazakhstan

2022-01-01 00:00:00

Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer’s disease

2022-01-01 00:00:00

Modulation of the Gut Microbiota in Memory Impairment and Alzheimer’s Disease via the Inhibition of the Parasympathetic Nervous System

2022-01-01 00:00:00

Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease